These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2078989)

  • 1. Post-antibiotic effect of isepamicin compared to that of other aminoglycosides.
    Minguez F; Agra M; Lurueña S; Ramos C; Prieto J
    Drugs Exp Clin Res; 1990; 16(5):231-5. PubMed ID: 2078989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compiled data on aminoglycoside, foremost netilmicin susceptibility of bacterial strains.
    Juhlin I; Tunevall G
    Scand J Infect Dis Suppl; 1980; Suppl 23():39-44. PubMed ID: 6782657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
    J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invitro comparative evaluation of aminoglycosides at a cancer centre.
    Biswas SK; Kelkar RS
    Indian J Cancer; 2002; 39(4):135-8. PubMed ID: 12928571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of nosocomial isolates against a new aminoglycoside isepamicin.
    Kapil A; Bali R; Das BK
    Indian J Med Res; 2001 Feb; 113():60-2. PubMed ID: 21910285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A; Montini G; Ramacciotti PG
    Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isepamicin (SCH 21420, 1-N-HAPA gentamicin B): microbiological characteristics including antimicrobial potency of spectrum of activity.
    Jones RN
    J Chemother; 1995 Jun; 7 Suppl 2():7-16. PubMed ID: 8622113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical comparative evaluation of aminoglycosides.
    Abbate GF; Alagia I; Giaquinto E; Giordano B; Leonessa V; Altucci P
    Chemioterapia; 1984 Dec; 3(6):378-84. PubMed ID: 6529780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo postantibiotic effect of isepamicin and other aminoglycosides in a thigh infection model in neutropenic mice.
    Minguez Minguez F; Izquierdo Izquierdo J; Caminero MM; Fuentes Martinez F; Prieto Prieto J
    Chemotherapy; 1992; 38(3):179-84. PubMed ID: 1511635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I; Voeckl J; Machka K
    Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consistent rates of kill of Staphylococcus aureus by gentamicin over a 6-fold clinical concentration range in an in vitro pharmacodynamic model (IVPDM).
    Schafer JA; Hovde LB; Rotschafer JC
    J Antimicrob Chemother; 2006 Jul; 58(1):108-11. PubMed ID: 16735429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antistaphylococcal activity of teicoplanin in association with other antibiotics.
    Cruciani M; Concia E; Monzillo V; Marone P; Perversi L
    Microbiologica; 1987 Apr; 10(2):197-207. PubMed ID: 2953955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of bacterial combinations on the post-antibiotic effect].
    Mínguez F; Aparicio P; Lurueña S; Cabronero MJ; Prieto J
    Enferm Infecc Microbiol Clin; 1990 Apr; 8(4):208-12. PubMed ID: 2090206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative post-antibiotic effect of five antibiotics against ten aerobic gram-positive cocci.
    Drabu YJ; Blakemore PH
    Drugs Exp Clin Res; 1990; 16(11):557-63. PubMed ID: 2151661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing nature of aminoglycoside resistance mechanisms and the role of isepamicin--a new broad-spectrum aminoglycoside. The Aminoglycoside Resistance Study Groups.
    Miller GH; Sabatelli FJ; Naples L; Hare RS; Shaw KJ
    J Chemother; 1995 Jun; 7 Suppl 2():31-44. PubMed ID: 8622109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily versus multiple-daily dosing of aminoglycosides.
    Craig WA
    J Chemother; 1995 Jun; 7 Suppl 2():47-52. PubMed ID: 8622110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro study of the synergistic effect of cefotiam- aminoglycoside combinations on strains of low susceptibility to this cephalosporin].
    Husson MO; Izard D; Leclerc H
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):466-8. PubMed ID: 3911141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of a microplate method for determining the post-antibiotic effect in Staphylococcus aureus and Escherichia coli.
    Stubbings WJ; Bostock JM; Ingham E; Chopra I
    J Antimicrob Chemother; 2004 Jul; 54(1):139-43. PubMed ID: 15150167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Resistance of blood culture isolates in vitro to 4 aminoglycoside antibiotics in Austria--1982/83].
    Mittermayer H; Rotter M; Thiel W; Breitfellner G
    Wien Klin Wochenschr; 1985 Mar; 97(7):334-9. PubMed ID: 3993043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of dactimicin and other aminoglycosides against bacteria producing aminoglycoside-modifying enzymes.
    Felmingham D; Jones K
    Drugs Exp Clin Res; 1989; 15(3):133-6. PubMed ID: 2752913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.